Cargando…

Resection of Early-Stage Second Primary Non-small Cell Lung Cancer After Small Cell Lung Cancer: A Population-Based Study

Introduction: A certain number of small cell lung cancer (SCLC) patients become long-term survivors after treatment, and they are at high risk to develop a second primary malignancy, including non-small cell lung cancer. However, the optimal management of early-stage second primary non-small cell lu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Rusi, Cai, Ling, Wang, Gongming, Wen, Yingsheng, Wang, Fang, Zhou, Ningning, Zhang, Xuewen, Huang, Zirui, Yu, Xiangyang, Xi, Kexing, Yang, Longjun, Zhao, Dechang, Lin, Yongbin, Zhang, Lanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013095/ https://www.ncbi.nlm.nih.gov/pubmed/32117785 http://dx.doi.org/10.3389/fonc.2019.01552

Ejemplares similares

Analysis of the tumor immune environment identifies an immune gene set–based prognostic signature in non-small cell lung cancer
por: Guo, Guangran, et al.
Publicado: (2022)

The independent prognostic effect of marital status on non-small cell lung cancer patients: a population-based study
por: Zhao, Dechang, et al.
Publicado: (2023)

A tumor microenvironment gene set–Based prognostic signature for non-small-cell lung cancer
por: Wen, Yingsheng, et al.
Publicado: (2022)

Development and validation of a preoperative noninvasive predictive model based on circular tumor DNA for lymph node metastasis in resectable non-small cell lung cancer
por: Zhang, Rusi, et al.
Publicado: (2020)

Development and validation of a prediction model for lung adenocarcinoma based on RNA-binding protein
por: Yang, Longjun, et al.
Publicado: (2021)

Segmental resection is associated with decreased survival in patients with stage IA non-small cell lung cancer with a tumor size of 21–30 mm
por: Yu, Xiangyang, et al.
Publicado: (2021)

The Independent Prognostic Effect of Lymph Node Dissection on Patients With Stage IA NSCLC With Different T Stages
por: Zhao, Dechang, et al.
Publicado: (2021)

Early Detection of Non-Small Cell Lung Cancer by Using a 12-microRNA Panel and a Nomogram for Assistant Diagnosis
por: Wang, Weidong, et al.
Publicado: (2020)

Extent of resection and lymph node evaluation in early stage metachronous second primary lung cancer: a population-based study
por: Zhang, Rusi, et al.
Publicado: (2020)

Impact of Different Types of Lymphadenectomy Combined With Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-small-cell Lung Cancer: A Large-Cohort Real-World Study
por: Wang, Weidong, et al.
Publicado: (2019)

Prognostic significance of combined preoperative platelet-to-lymphocyte ratio and lymphocyte-to-monocyte ratio in patients undergoing surgery with stage IB non-small-cell lung cancer
por: Chen, Yongqiang, et al.
Publicado: (2018)

Mutation-Derived Long Noncoding RNA Signature Predicts Survival in Lung Adenocarcinoma
por: Yang, Longjun, et al.
Publicado: (2022)

Ten-year trends of the clinicopathological characteristics, surgical treatments and survival outcomes of operable lung cancer patients in monocenter: a retrospective cohort study
por: Zhao, Dechang, et al.
Publicado: (2023)

Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

Ferroptosis-related lncRNAs signature to predict the survival and immune evasion for lung squamous cell carcinoma
por: Zhang, Rusi, et al.
Publicado: (2022)

Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules
por: Xi, Kexing, et al.
Publicado: (2019)

SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial‐mesenchymal transition (EMT) in lung adenocarcinoma
por: He, Xiaotian, et al.
Publicado: (2023)

The value of preoperative Glasgow Prognostic Score and the C-Reactive Protein to Albumin Ratio as prognostic factors for long-term survival in pathological T1N0 esophageal squamous cell carcinoma
por: Yu, Xiangyang, et al.
Publicado: (2018)

First-generation EGFR tyrosine kinase inhibitor therapy in 106 patients with compound EGFR-mutated lung cancer: a single institution’s clinical practice experience
por: Yu, Xiangyang, et al.
Publicado: (2018)

Evaluation of the significance of subcarinal lymph node dissection in stage IB non‑small cell lung cancer
por: Wang, Feng, et al.
Publicado: (2023)

Prognosis and distribution of lymph nodes metastases in resectable primary pulmonary lymphoepithelioma‐like carcinoma: A large cohort from a single center
por: Yu, Xiangyang, et al.
Publicado: (2018)

A comparison of MASS-PCR and ARMS-PCR for the detection of lung cancer gene mutation
por: Cai, Ling, et al.
Publicado: (2019)

A new method for accurately localizing and resecting pulmonary nodules
por: Wang, Gongming, et al.
Publicado: (2020)

A Model Shows Utility in Predicting Postoperative Recurrence and Distant Metastasis in Curatively Resected Esophageal Squamous Cell Cancer
por: Wang, Weidong, et al.
Publicado: (2019)

Multi-region exome sequencing reveals the intratumoral heterogeneity of surgically resected small cell lung cancer
por: Zhou, Huaqiang, et al.
Publicado: (2021)

Emerging therapies for small cell lung cancer
por: Yang, Sen, et al.
Publicado: (2019)

SUMOylation-triggered ALIX activation modulates extracellular vesicles circTLCD4-RWDD3 to promote lymphatic metastasis of non-small cell lung cancer
por: Diao, Xiayao, et al.
Publicado: (2023)

Role of chemotherapy for survival in patients with second primary non‐small cell lung cancer
por: Wang, Zhile, et al.
Publicado: (2020)

Prognostic study for survival outcome following the treatment of second primary lung cancer in patients with previously resected non‐small cell lung cancer
por: Wu, Yijun, et al.
Publicado: (2020)

Genomic and immunological profiles of small-cell lung cancer between East Asians and Caucasian
por: Lin, Anqi, et al.
Publicado: (2022)

Second- and third-generation ALK inhibitors for non-small cell lung cancer
por: Wu, Jingjing, et al.
Publicado: (2016)

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer
por: Lazzari, Chiara, et al.
Publicado: (2017)

BRAF-Mutated Non-Small Cell Lung Cancer: Current Treatment Status and Future Perspective
por: Yan, Ningning, et al.
Publicado: (2022)

Small cell lung cancer.
por: Leonard, R. C.
Publicado: (1989)

Transformation of non-small cell lung cancer into small cell lung cancer in a patient with advanced lung cancer: a case report
por: Yang, Zhengyuan, et al.
Publicado: (2021)

Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer
por: Zhang, Caifa, et al.
Publicado: (2022)

Surgical Resection for Small Cell Lung Cancer: Pneumonectomy versus Lobectomy
por: Yuequan, Jiang, et al.
Publicado: (2012)

Prognostic significance of TOP2A in non-small cell lung cancer revealed by bioinformatic analysis
por: Ma, Wenxia, et al.
Publicado: (2019)

Small nucleolar RNA 78 promotes the tumorigenesis in non-small cell lung cancer
por: Zheng, Di, et al.
Publicado: (2015)

Activity of ceritinib in crizotinib-resistant ROS1-rearranged non-small-cell lung cancer patients
por: Zhang, Huixian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3580totb9hfjfmuenukdp62qt6